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Abstract 33	
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to antagonize 34	
the innate immune response. An atypical PRRSV strain A2MC2 is capable of inducing synthesis 35	
of type I interferons (IFNs) in cultured cells. Here, we show that the middle half of the A2MC2 36	
genome is needed for triggering the IFN synthesis. First, a cDNA infectious clone of this atypical 37	
strain was constructed as a DNA-launched version. Virus recovery was achieved from the 38	
infectious clone and the recovered virus, rA2MC2, was characterized. The rA2MC2 retained the 39	
feature of interferon induction in cultured cells. Infection of pigs with the rA2MC2 virus caused 40	
viremia similar to that of the wild type virus. Chimeric infectious clones were constructed by 41	
swapping genomic fragments with a cDNA clone of a moderately virulent strain VR-2385 that 42	
antagonizes IFN induction. Analysis of the rescued chimeric viruses demonstrated that the 43	
middle two fragments, ranging from nt4545 to nt12709 of the A2MC2 genome, were needed for 44	
the IFN induction, whereas the chimeric viruses containing any one of the two A2MC2 45	
fragments failed to do so. The results and the cDNA infectious clone of the IFN-inducing 46	
A2MC2 will facilitate further study of its biology, ultimately leading towards the development of 47	
an improved vaccine against PRRS.  48	
  49	
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INTRODUCTION 50	
Porcine reproductive and respiratory syndrome virus (PRRSV) infection of pigs has a 51	
high economic impact on swine production across the world, and has resulted in an estimated 52	
$664 million loss per year in the United States alone [1, 2]. PRRSV is a single-stranded positive-53	
sense RNA virus belonging to the family Arteriviridae, order Nidovirales [3]. There are two 54	
PRRSV genotypes: Type 1 (European) and Type 2 (North American), which are classified into 55	
two species in the genus Porartevirus: PRRSV-1 and PRRSV-2 in the new taxonomy [4, 5]. The 56	
genome of PRRSV is around 15 kb in length and contains at least ten open reading frames 57	
(ORFs). ORF1a and ORF1b occupy two thirds of the viral genome and encode non-structural 58	
proteins that are needed for viral replication, while ORFs 2-7 encode structural proteins. PRRSV 59	
mainly targets pulmonary alveolar macrophages (PAMs) during acute infection of pigs [6]. 60	
MARC-145 cells, derived from a monkey kidney, are generally used for PRRSV propagation in 61	
vitro [7].  62	
Host innate immune responses play a critical role against early viral infection. The 63	
pattern recognition receptors (PRR) for RNA viruses include RIG (retinoic-acid-inducible gene)-64	
I-like receptors (RLRs) and Toll-like receptors (TLRs) [8, 9]. Stimulation of RLR and TLR 65	
signaling pathways leads to activation of IFN regulatory factor 3 (IRF-3), IRF-7 and NF-κB 66	
(nuclear factor kappa-light-chain-enhancer of activated B cells), followed by induction of type I 67	
interferons (IFNs) (i.e. IFN-α and β) and expression of inflammatory cytokines. Type I IFNs are 68	
critical to innate immunity against viral infections and play an important role in activation of the 69	
adaptive immune response [10, 11].  70	
PRRSV appears to inhibit synthesis of type I IFNs in vivo [12-14] and in vitro [12, 15, 71	
16]. Recovered virus from an infectious clone of a high-pathogenic PRRSV isolate was reported 72	
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to induce IFNs in infected pigs, which may be because of its significant higher-level replication 73	
(100-1000 fold) and induced more severe inflammatory response than VR-2332 [17]. An 74	
atypical PRRSV strain A2MC2 was discovered to induce high level IFNs in cultured cells, 75	
whereas other strains tested, including PRRSV VR-2332, Ingelvac® PRRS MLV (Boehringer 76	
Ingelheim, Inc; hereinafter referred as MLV vaccine strain), and VR-2385, antagonize IFN 77	
induction [18]. Inoculation of pigs with the A2MC2 virus leads to earlier onset and higher virus-78	
neutralizing antibodies than the MLV vaccine strain [19]. Neutralizing antibodies against 79	
PRRSV confer protection of pregnant sows against reproductive failure induced by virulent 80	
strain challenge [20]. Passive transfer of PRRSV-neutralizing antibodies to young weaned pigs 81	
blocks PRRSV viremia after challenge [21].  82	
The interferon induction by strain A2MC2 sustains serial passaging of the virus in 83	
MARC-145 cells for 90 passages for attenuation, as the A2MC2-P90 induces IFNs similarly to 84	
the wild type virus [22]. This high-passaged virus, A2MC2-P90, is avirulent and induces higher 85	
virus-neutralizing antibodies than the MLV vaccine strain. The interferon induction of A2MC2 86	
and its ability to induce high levels of neutralizing antibodies indicate that this virus carries 87	
unique feature in its genomic sequence, which might correspond to pathogen-associated 88	
molecular patterns (PAMP). The PAMP is prone to be recognized by host PRR and remains 89	
intact in the avirulent A2MC2-P90 virus.  90	
In the present study, the objective was to construct a cDNA infectious clone of A2MC2 91	
and to study the genomic source of the interferon induction. A DNA-launched infectious clone 92	
was constructed, and virus recovery was achieved. The recovered virus maintained the feature of 93	
IFN induction in cultured cells. When the recovered virus was tested in the pig model, it caused 94	
pathology similar to that of the wild type virus. Chimeric clones of A2MC2 with moderately 95	
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virulent PRRSV strain VR-2385 that does not induce IFNs were constructed. Analysis of the 96	
recovered chimeric viruses demonstrated that the middle half of the A2MC2 genome is essential 97	
for the interferon induction.  98	
  99	
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RESULTS 100	
Construction of cDNA infectious clone of atypical PRRSV strain A2MC2 and 101	
determination of the growth property of the recovered virus  102	
 A cDNA infectious clone of strain A2MC2 was constructed as a DNA-launched version 103	
(Fig. 1a). Sequences of hammerhead ribozyme and hepatitis delta virus ribozyme were added at 104	
the 5’ and 3’ terminus, respectively, of the cDNA of A2MC2. The full-length PRRSV sequence 105	
in the resulting plasmid pCAGEN-A2MC2-Rz was confirmed by DNA sequencing. MARC-145 106	
cells were transfected with the pCAGEN-A2MC2-Rz plasmid to recover virus. The transfected 107	
cells were harvested four days after transfection and supernatant of the cell lysate was passaged 108	
in fresh cells. Typical cytopathic effect of PRRSV was visible 48 h post inoculation (hpi), and 109	
the virus proliferation was verified by IFA with an N-specific monoclonal antibody (Fig. 1b). 110	
Partial DNA sequencing of the progeny virus confirmed they were derived from the infectious 111	
clone.    112	
 The rA2MC2 virus was propagated in MARC-145 cells for a multi-step growth curve and 113	
a plaque assay. The virus yields for the cells with inoculum at an MOI (multiplicity of infection) 114	
of 0.01 peaked at 72 hpi (Fig. 2a). The virus yields for the cells inoculated with an MOI of 0.01 115	
were higher than the cells inoculated with an MOI of 0.1 and 1.0. The virus yields for the cells 116	
inoculated with an MOI of 1.0 decreased along with time extension. The virus yields for the cells 117	
inoculated with an MOI of 0.1 were similar to those of parental wild type A2MC2 virus in the 118	
same amount of inoculum (Fig. 2a).  119	
 A plaque assay was conducted in MARC-145 cells to compare the rA2MC2 and its 120	
parental A2MC2 virus. Both parental A2MC2 and rA2MC2 had similar plaque sizes, 3-4 mm in 121	
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diameter (Fig. 2b). The results indicate that the rA2MC2 virus had a growth property similar to 122	
its parental virus.  123	
The recovered A2MC2 virus induces interferon synthesis 124	
 As the wild type A2MC2 induces interferon production in cultured cells [18], we tested 125	
whether the rA2MC2 virus kept the feature of IFN induction. The supernatant of rA2MC2-126	
infected MARC-145 cells was used for an interferon bioassay in Vero cells. Results showed that 127	
NDV-GFP replication was inhibited in the Vero cells treated with the rA2MC2 supernatant 128	
diluted up to 1:16, similar to the wild type A2MC2 (Fig. 3a). This suggests that rA2MC2 129	
induced production of interferons, which led to the suppression of NDV replication in the Vero 130	
cells, in a similar capacity to the wild type A2MC2 virus.   131	
Expression of interferon-stimulated genes (ISG) was also determined to confirm the 132	
effect of the treatment of Vero cells. Compared with the mock-treated cells, the cells treated with 133	
supernatant samples of rA2MC2 and parental wild type A2MC2 at 24 hpi had ISG15 transcript 134	
level increased by 64 and 81-fold, respectively (Fig. 3b). There is no significant difference 135	
between the ISG15 levels in cells treated with rA2MC2 or wild type A2MC2 supernatants. 136	
STAT2 and RIG-I are also known to be upregulated by type I IFNs [18, 22]. The protein levels 137	
of STAT2 and RIG-I in the rA2MC2-infected MARC-145 cells at both 24 and 48 hpi were 138	
upregulated (Fig. 3c). The result demonstrated that rA2MC2 kept the feature of IFN induction.  139	
PAMs are the major target cells for PRRSV infection in vivo. We inoculated primary 140	
porcine PAMs with the rA2MC2 virus and found that the virus replicated in PAMs and induced 141	
IFNs (data not shown). This indicates the recovered virus is similar to the wild type A2MC2 142	
virus in inducing IFN synthesis in the cultured cells.  143	
Pig study 144	
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 An animal experiment was conducted by inoculating 3-week-old PRRSV-negative piglets 145	
with the rA2MC2 virus. The pigs were euthanized at 14 days post-infection (DPI). Compared 146	
with the pigs inoculated with parental A2MC2 virus, the pigs infected with the rA2MC2 virus 147	
had similar lesion scores, though there were some low responders (Fig. 4a).  148	
Real-time PCR was conducted to determine PRRSV RNA in serum samples of 14 DPI. 149	
The average PRRSV RNA levels for the pigs infected with the rA2MC2 and the parental A2MC2 150	
virus were 4.55 and 4.46 log10 copies/ml, respectively (Fig. 4b). There was no significant 151	
difference in the PRRSV RNA levels between the two groups. These results suggest that the 152	
rA2MC2 virus has similar virulence and replication kinetics in pigs compared to its parental 153	
A2MC2 virus. 154	
Construction of chimeric cDNA infectious clones and determination of the growth property 155	
of the recovered chimeric virus  156	
 To determine the genetic source of A2MC2 virus for interferon induction, we constructed 157	
three chimeric A2MC2 infectious clones by genomic fragment swapping with pIR-VR2385 (Fig. 158	
5a). VR-2385 does not induce IFNs [18] and the pIR-VR2385 was robust in virus recovery [23]. 159	
The cDNA sequence of the viral genome in pIR-VR2385 is shorter than the A2MC2 sequence 160	
due to deletion in nsp2 [23]. So the nucleotide positions of the three restriction enzymes are 161	
different from A2MC2 cDNA (Fig. 5a). The F2, F3, and F1-F3 fragments in pIR-VR2385 were 162	
replaced with their counterparts of A2MC2, resulting in chimeric clones: pIR-VR2385/A2F2, 163	
pIR-VR2385/A2F3, and pIR-VR2385/A2F123. MARC-145 cells were transfected with these 164	
chimeric infectious clones as well as pIR-VR2385 and pIR-A2MC2 plasmids for virus recovery 165	
separately. The virus recovery was successful from all the clones.  166	
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 The chimeric viruses were subjected to growth property assay in MARC-145 cells. The 167	
virus yields for the cells inoculated with the rA2F2 and rVR2385 from 48 to 96 hpi were similar 168	
(Fig. 5b). The virus yields for the cells inoculated with the rA2MC2 and rA2F3 were similar, 169	
approximately 0.5-1 log lower than rA2F2 and rVR2385 at 72 and 96 hpi. All the viruses had 170	
similar yields at 48 hpi. The yields for the rA2F123 virus at 72 and 96 hpi were lower than all the 171	
other four viruses. The results indicate that the chimera rA2F2 is similar to rVR2385 in 172	
replication rate, chimera rA2F3 is similar to rA2MC2, and chimera rA2F123 has a lower 173	
replication rate than both rVR2385 and rA2MC2. 174	
 A plaque assay was conducted in MARC-145 cells to compare the chimeric viruses. All 175	
the chimeric viruses had similar plaque sizes, 2-4 mm in diameter (Fig. 5c).  176	
The middle half of the strain A2MC2 genome is essential for interferon induction 177	
For interferon bioassay, the culture supernatants of MARC-145 cells infected with the 178	
chimeric viruses were used to treat Vero cells. Results showed that NDV-GFP replication was 179	
inhibited in the Vero cells treated with the culture supernatants of rVR/A2F123 and rA2MC2 180	
virus in a dilution up to 1:16 (Fig. 6a). However, treatment with the culture supernatants of 181	
rVR/A2F2, rVR/A2F3, and rVR2385 viruses had a minimal effect on the NDV-GFP replication 182	
when compared to the mock-treated cells. A2MC2 has the same sequence in fragment 1 (nt1-183	
4544) as VR-2332, and the latter does not induce IFNs in MARC-145 cells [18]. So both 184	
fragments 2 and 3 (nt4545-12709) are critical for the IFN induction.   185	
           To confirm this observation, immunoblotting to determine the RIG-I protein level in 186	
MARC-145 infected with the chimeric viruses was conducted. Compared with the mock-infected 187	
cells, the MARC-145 cells infected with rVR/A2F123 chimeric virus at 48 hpi had higher RIG-I 188	
protein level, whereas the cells infected with rVR/A2F2 and rVR/A2F3 chimeric viruses had a 189	
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slight reduction (Fig. 6b). The rVR2385-infected cells had lower RIG-I level than the mock-190	
infected cells. This confirmed that the rVR/A2F123 chimeric virus induced interferon production 191	
in MARC-145 cells and the presence of both fragments 2 and 3 of the A2MC2 genome is 192	
required for the sensing by host pattern recognition receptors.   193	
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DISCUSSION  194	
 Although it has been nearly 30 years since the first reports of PRRS, broadly effective 195	
vaccines against PRRSV infection are still not available due to the genetic diversity of PRRSV 196	
isolates and apparent lack of cross-protection between isolates [2]. It is known that PRRSV 197	
strains generally antagonize interferon synthesis [14, 18, 24].  The effect of PRRSV replication 198	
on IFN induction appears to be variable among different strains and different cell types. PRRSV 199	
field isolates have variable suppressive effect on IFN-! induction in cultured PAM cells [16]. 200	
The interferon induction by PRRSV strain A2MC2 is a unique feature of this virus. Considering 201	
the importance of interferons in activating the adaptive immune response [11, 25], this feature is 202	
desirable in vaccine development against PRRSV. Type I IFNs have an important role in the 203	
differentiation of CD4+ and CD8+ T cells [11, 25]. This study identified that the middle half of 204	
the A2MC2 genome is pivotal for IFN induction by chimeric infectious clone analyses. The 205	
rescued A2MC2 virus has the capability of IFN induction in cultured cells like its parental strain. 206	
Treatment of Vero cells with the culture supernatants from rA2MC2-infected cells induced 207	
expression of ISG15, RIG-I, and STAT2, which indicates the activation of IFN signaling. The 208	
expression of the interferon-activated genes was confirmed at both the RNA and the protein 209	
levels. These results suggest that the genetic feature of A2MC2 is maintained in the cDNA 210	
infectious clone. 211	
 The recovered rA2MC2 virus maintained the feature of IFN induction in cultured cells. 212	
The rA2MC2 virus has growth properties in terms of multi-step growth and plaque formation 213	
similar to its parental virus. The cells infected with rA2MC2 inoculum at an MOI of 0.01 had 214	
higher viral yields than the cells inoculated with an MOI of 0.1 and 1.0, which indicates less 215	
inoculum leads to more efficient virus replication. This result is also consistent with the feature 216	
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of IFN induction. The lower the inoculum, the less IFN induction in the cells and the weaker the 217	
antiviral response the cells would mount. The virus in the cells at low level would have a better 218	
chance to replicate to high level without triggering a rigorous antiviral response than high level 219	
of virus in the initial inoculum.  220	
 The rA2MC2 virus led to pathology and viremia in pigs similar to its parental virus, 221	
though the lung lesion scores were numerically variable among the pigs infected. This is possible 222	
due to the variation of individual pigs used in this study, some of which were low responders. 223	
This is also indicated by their similar viremia levels. The rA2MC2 virions are expected to be a 224	
more homogenous population than the wild type virus though the latter was plaque purified [18].  225	
 The chimeric cDNA clones of A2MC2 and VR-2385 were constructed. Similar growth 226	
trend and yields from 48 to 96 hpi were observed between the rA2F2 and rVR2385, as well as 227	
between the rA2F3 and rA2MC2. All the five recovered viruses have similar yields at 48 hpi. 228	
The rA2F123 has similar yields to rVR2385, but lower yields than the other four viruses at 72 229	
and 96 hpi, which may be because rA2F123 induces IFNs. The yields of the rA2MC2 virus was 230	
slightly higher than rA2F123 in the two late time points when the cells were inoculated at this 231	
amount of inoculum. It is not known whether the fragment 4 that are different between these two 232	
recovered IFN-inducing viruses contributes to the variation in late virus replication.  233	
The chimeric clones of A2MC2 and VR-2385 were used to study the genomic source of 234	
the IFN induction. Since the nucleotide sequence of A2MC2 fragment 1 (nt1-4544) is the same 235	
as VR-2332 and the latter antagonizes IFN induction [18], the fragment 1 has no pivotal role in 236	
the A2MC2 induction of IFNs. Thus, the genomic source for the IFN induction must be from the 237	
middle two fragments. The results from analyzing the chimeric viruses demonstrated that both 238	
fragment 2 and 3 (nt4545-12709) are required for IFN induction. The sequence of nt4545-12709 239	
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in the A2MC2 genome encodes proteins of C-terminal 126 amino acid residues of nsp2, nsps 3-240	
12, and N-terminal 213 residues of GP2a. Among these PRRSV nsps, nsp2, nsp4, and nsp11 are 241	
reported to inhibit IFN induction [14, 26]. A2MC2 has the identical nsp2, nsp4, and nsp11 as 242	
VR-2332 or MLV [18]. Thus, lack of inhibition of IFN induction by these proteins is not 243	
possible.  244	
Our results indicate that the middle half genome of A2MC2 contributes to the PAMP 245	
recognition by host PRR. RIG-I and MDA5 are the PRR to sense viral RNA in the cytoplasm. 246	
RIG-I preferentially recognizes the 5’ terminus of the virus RNA, including both the genomic 247	
and subgenomic RNA for PRRSV. A prerequisite for RIG-I recognition is the presence of 5’ 248	
diphosphate or triphosphate [27, 28]. Conversely, MDA5 recognizes an internal duplex structure 249	
of long double-stranded RNA (dsRNA) [29, 30]. RIG-I was previously reported to be the PRR 250	
interfered by PRRSV to antagonize IFN induction [31]. For IFN induction by strain A2MC2, the 251	
role of RIG-I is unknown. Presumably, dsRNA is formed during PRRSV replication, and the 252	
middle half of the A2MC2 genome confers the internal duplex structure for MDA5 recognition. 253	
This is consistent with our observation that A2MC2 replication is needed for the IFN induction 254	
as UV-inactivated A2MC2 virus cannot trigger IFNs [18]. We speculate that many PRRSV 255	
strains like VR-2332 and VR-2385 that antagonize IFN induction may escape the MDA5 256	
recognition by formation of a different internal duplex structure.  257	
 Our data indicate that both fragments 2 and 3 (nt4545 to nt12709) of A2MC2 are pivotal 258	
for the possible internal duplex structure for MDA5 recognition. Replacement of either F2 or F3 259	
in the cDNA clone of VR-2385 with the corresponding fragment of A2MC2 failed to confer the 260	
chimeric viruses the capability to induce IFNs. In addition, the chimeric viruses from the F2 or 261	
F3 chimeric clones were unable to evoke elevation of RIG-I. In contrast, the chimeric virus 262	
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rA2F123 containing both the F2 and F3 of A2MC2 induced IFNs and triggered the elevation of 263	
RIG-I protein level. The result indicates that the A2MC2 fragment 4 (nt12710-3’terminus) 264	
covering ORFs 3-7 appears not to play a decisive role in the IFN induction. A2MC2 ORF2 265	
(nt12073-12843) overlaps with the 3’terminus of F3 and the 5’terminus of fragment 4. It is not 266	
known whether the ORF2 sequence contributes to the potential internal duplex structure for 267	
MDA5 recognition. The requirement of both fragment 2 and 3 in IFN induction might be 268	
coincidental. Further study is needed to define the minimum sequence and/or nucleotides that are 269	
required for the IFN induction. 270	
Though the fragment 1 is assumed to have no pivotal role in the IFN induction by strain 271	
A2MC2, other studies have shown three proteins encoded by this part of the genome, nsp1α, 272	
nsp1β, and nsp2, involve in PRRSV inhibition of IFN induction [14, 24, 32]. Reversal of the 273	
inhibition leads to improvement of IFN induction. Site-directed mutagenesis of R128 and R129 274	
of nsp1β reduced its inhibition of IFN induction and led to improvement of the innate and 275	
adaptive immune responses by the mutant virus [33]. A synthetic PRRSV strain that was 276	
prepared on the basis of a consensus genome from alignment of 59 full-length genomes is shown 277	
to induce IFNs [34] and elicits heterologous protection [35]. The IFN induction phenotype of the 278	
synthetic PRRSV was mapped to the 3.3 kb genome encoding nsp1α, nsp1β, and N-terminal part 279	
of nsp2 [34]. Our data indicates that A2MC2 has a unique mechanism to trigger IFN synthesis, 280	
which is presumed to begin before the nsps are able to mount sensible suppression. This 281	
presumption is in consistent with our result that replication kinetics of A2MC2 is inverse 282	
proportional to the inoculum MOI. This mechanism is stable during serial passaging for 90 times 283	
in cultured cells since the A2MC2-P90 maintains the feature of IFN induction [22].  284	
 In conclusion, the middle half genome of strain A2MC2 is pivotal for its IFN induction. 285	
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The DNA-launched cDNA infectious clone of A2MC2 was constructed, and the recovered virus 286	
carries the unique feature of interferon induction in cultured cells. Further study using the 287	
A2MC2 cDNA infectious clone is warranted for examination of the precise mechanism of IFN 288	
induction and development of an improved vaccine against PRRS.  289	
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MATERIALS AND METHODS 290	
Cells and viruses 291	
Vero (ATCC CCL-81) and MARC-145 [7] cells were grown in DMEM (Dulbecco's 292	
Modified Eagle's Medium) supplemented with 10% fetal bovine serum (FBS). CRL2843 cells 293	
(porcine macrophages, ATCC) were cultured in RPMI1640 medium supplemented with 10% 294	
FBS. Primary PAM cells were prepared from 4-8-week-old piglets and cultured in RPMI1640 295	
medium supplemented with 10% FBS [36].  296	
PRRSV strains VR-2385 (passage 15) and A2MC2 (passage 10) were propagated and 297	
titrated in MARC-145 cells. Virus yields were titrated by 10-fold serial dilutions and presented 298	
as the median tissue culture infectious dose (TCID50) [37]. Newcastle disease virus strain LaSota 299	
carrying the gene of green fluorescence protein (NDV-GFP) was propagated in embryonated 300	
eggs and titrated in Vero cells [38].  301	
RNA isolation, reverse transcription, PCR and real-time PCR  302	
Total RNA was isolated using the TRIzol® LS Reagent (Thermo Fisher Scientific Inc., 303	
Waltham, MA) following the manufacturer’s instructions. Reverse transcription and PCR (RT-304	
PCR) and real-time PCR (RT-qPCR) were conducted to amplify cDNA for cloning or to 305	
determine PRRSV RNA levels [36, 39]. To normalize the total input RNA, ribosomal protein 306	
L32 (RPL32) RNA was measured. Specifically, the analysis of the relative transcript levels was 307	
performed by normalization of RPL32 in comparison with controls [40].  308	
Construction of cDNA clone of PRRSV strain A2MC2 309	
The strategy to construct the cDNA clone of A2MC2 (passage 10) is illustrated in Fig. 1a 310	
[41]. PCR was done to amplify four fragments spanning the full-length cDNA of strain A2MC2 311	
genomic RNA. Primers used in the PCR are listed in Table 1. The unique restriction sites FseI 312	
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(nt4545), PmeI (nt7692) and BsrGI (nt12709) in the A2MC2 genome were used to assemble the 313	
cDNA clone. SphI and PacI were also used to clone the cDNA into the target vector pCAGEN, 314	
which was a gift from Connie Cepko (Addgene plasmid # 11160) ([42]. A stuffer sequence 315	
containing these restriction sites was designed and ligated into pCAGEN at EcoRI/XhoI sites to 316	
generate the pCAGEN-Stuffer. The PCR products digested with the restriction enzymes were 317	
ligated into the pCAGEN-Stuffer vector in the following order: F1, F4, F3 and F2 to generate 318	
pCAGEN-A2MC2. DNA sequencing was done to confirm the cloned fragments. For insertion of 319	
a hepatitis delta virus ribozyme to the 3’end cDNA of the virus genome, two oligos A2-320	
3endRiboF and A2-3endRiboR were annealed and digested with PacI before ligation into 321	
pCAGEN-A2MC2 that was prepared with PacI digestion. DNA sequencing was done to confirm 322	
the addition, orientation and correct sequence of the two ribozymes in the recombinant 323	
pCAGEN-A2MC2-Rz. 324	
Correction of point mutations in the cDNA clone was done with Thermo Scientific™ 325	
Phusion Site-Directed Mutagenesis Kit (Thermo Fisher Scientific). The cDNA clone of PRRSV 326	
VR-2385, pIR-VR2385-CA, was a gift from Xing-Jin Meng [23] and used for fragment 327	
swapping with A2MC2 cDNA to generate chimeric clones and the pIR-A2MC2 plasmid. The 328	
rA2MC2 virus (passage 6) was used in experiments in this study. 329	
Interferon bioassay  330	
The presence of interferons in the culture supernatant samples was determined as 331	
described previously [18]. Briefly, culture supernatant samples from PRRSV-infected MARC-332	
145 cells were diluted and added to Vero cells. After overnight incubation, the Vero cells were 333	
inoculated with NDV-GFP, as it is sensitive to IFN-induced antiviral effect. Fluorescence 334	
microscopy was conducted 24 h after NDV inoculation to observe GFP-positive cells.  335	
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Immunofluorescence assay (IFA) 336	
PRRSV propagation in MARC-145 cells on coverglass was detected with IFA using an 337	
N-specific monoclonal antibody EF11 [43]. DyLight™ 488 conjugated goat anti-mouse IgG 338	
(Rockland Immunochemicals Inc., Limerick, PA) was used to detect the EF11 binding to the N 339	
protein in the infected cells. SlowFade Gold antifade reagent containing 4’6-diamidino-2-340	
phenylindole (DAPI) (Thermo Fisher Scientific) was used for mounting the coverglass onto the 341	
slide before observation under fluorescence microscopy. 342	
Western blotting  343	
Total proteins in the cell lysate samples were separated by sodium dodecyl sulfate-344	
polyacrylamide gel electrophoresis (SDS-PAGE), followed by Western blotting as described 345	
previously [44]. Antibodies against STAT2, RIG-I, and GAPDH (Santa Cruz Biotechnology, 346	
Inc., Dallas, TX) and horseradish peroxidase-conjugated secondary antibodies (Rockland 347	
Immunochemicals Inc.) were used in this study.  348	
Plaque assay 349	
Plaque assay in MARC-145 cells was done to compare the recovered virus with its 350	
parental virus [18, 22]. PRRSV was diluted to 10 and 100 TCID50 per ml and added to the 351	
monolayer cells. After 2 h incubation, the inoculum was removed and 0.5% agarose overlay 352	
containing complete growth medium was added onto the cells. Plaques were stained with neutral 353	
red and observed after overnight incubation.  354	
DNA Sequencing 355	
DNA sequencing was performed with ABI Prism 3130 Genetic Analyzer (Thermo Fisher 356	
Scientific). Sequence assembly and analysis was done with LaserGene Core Suite (DNASTAR 357	
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Inc., Madison, WI). The GenBank accession number of the cDNA sequence of A2MC2 genomic 358	
RNA is JQ087873. 359	
Animal study  360	
The animal study was approved by the Institutional Animal Care and Use Committees 361	
(IACUC) of Iowa State University and the University of Maryland and according to relevant 362	
guidelines and policies for the care and use of laboratory animals. Three-week-old PRRSV-363	
negative piglets were randomly divided into three groups with 4 pigs in each group. The piglets 364	
in groups 1 and 2 were inoculated with 1 ml of wild type A2MC2 (passage 10) and rA2MC2 365	
(passage 6), respectively, at 105 TCID50/ml via intranasal inoculation (I.N.), while group 3 was 366	
mock-infected with phosphate-buffered saline (PBS) pH7.2. The pigs were observed daily. 367	
Blood samples were collected prior to inoculation and at 14-day post-infection (DPI).  368	
The pigs were euthanized on DPI14 by pentobarbital overdose (FATAL-PLUS, Vortech 369	
Pharmaceuticals, LTD. Dearborn, MI). Visible macroscopic lung lesions were scored and 370	
recorded as previously described [45, 46].  371	
Statistical analysis 372	
Differences between treatment and control samples were assessed by the t-test (Mann-373	
Whitney test (nonparametric)) in GraphPad Prism. A two-tailed P-value of less than 0.05 was 374	
considered statistically significant.  375	
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Table 1. Primers used in this study 511	
Primer* Sequence (5’ to 3’)† 
A2HeadRiboF1 ACATGCATGCGGCGCGCCACATCATCTGATGAGTCCGTGAGGACGAAACGGTACCCG 
A2HeadRiboF2 CGTGAGGACGAAACGGTACCCGGTACCGTCATATGACGTATAGGTGTTGGCTCTATGC 
A2-4618R CTGGGCGACCACAGTCCTA 
A2-4095F TGGCTTTTGCTGTTGGTCTGTTC 
A2-8077R GAGCGTCGCCGCGCCTAATGTC 
A2-7255F GGATGAGGACCGTTTGAATAAG 
A2-13200R CCGCCGTCGACTTGATGTTGGTAA 
A2-11936F GTGAGGACTGGGAGGATTACA 
A2-3endR GTCTTTAATTAACTAGTTTTTTTTTTTTTTTTTTTTTAATTTCG 
A2-3endRiboF CCTTAATTAAGGCCGGCATGGTCCCAGCCTCCTCGCTGGCGCCGGCTGGGCAACATTCC
GAG 
A2-3endRiboR GGTTAATTAAGTCCCATTCGCCATTACCGAGGGGACGGTCCCCTCGGAATGTTGCCCAG
CCG 
StufferF AATTCGCATGCATAGCCGGCCGGCCTACAGCGTTTAAACGTCCGATGTACACCTGACTTA
ATTAAC 
StufferR TCGAGTTAATTAAGTCAGGTGTACATCGGACGTTTAAACGCTGTAGGCCGGCCGGCTATG
CATGCG 
 512	
*The primers were designed on the basis of the PRRSV A2MC2 cDNA sequence 513	
(GenBank accession number JQ087873). 514	
†Italicized letters denote target sites of restriction enzymes used in the study.  515	
 516	
  517	
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FIGURE LEGENDS 518	
Fig. 1. Construction of a cDNA infectious clone of PRRSV strain A2MC2. (a) Schematic 519	
illustration of the strategy for the cloning of A2MC2 cDNA into pCAGEN vector. F1, F2, F3, 520	
and F4 denote four fragments amplified from cDNA of A2MC2. The numbers 4545, 7692, and 521	
12709 above the insert indicate nucleotide positions of the restriction enzymes FseI, PmeI and 522	
BsrGI in the cDNA of A2MC2 (GenBank accession number JQ087873). The lower four lines 523	
indicate PCR amplified fragments. The five restriction enzymes used to assemble the full-length 524	
cDNA are indicated above each fragment. H-Rz: hammerhead ribozyme. D-Rz: hepatitis delta 525	
virus ribozyme. (b) Immunofluorescence assay (IFA) of MARC-145 cells infected with 526	
recovered virus from the cDNA infectious clone of A2MC2 (rA2MC2).  527	
Fig. 2. Growth property of the rA2MC2 virus. (a) Multi-step growth curve of the rA2MC2 virus. 528	
MARC-145 cells were infected with rA2MC2 virus at an MOI of 1, 0.1, and 0.01, respectively. 529	
Culture supernatants were collected daily for virus yield titration. The virus titers (log10 530	
TCID50/ml) were determined in MARC-145 cells. Error bars represent standard errors of three 531	
repeated experiments. Wild type parental A2MC2 virus was included as a control (0.1 MOI 532	
WT). (b) Plaque assay of rA2MC2 and parental A2MC2 virus in MARC-145 cells. The bars in 533	
the images correspond to 10 mm.  534	
Fig. 3. The rA2MC2 virus induces type I interferons in MARC-145 cells. (a) Interferon bioassay 535	
in Vero cells. Cell culture supernatants from rA2MC2-infected MARC-145 cells collected at 24 536	
hpi were diluted and added to Vero cells. 12 h later, the cells were infected with NDV-GFP. 537	
Fluorescence microscopy was conducted 24 h after NDV-GFP inoculation. Culture supernatant 538	
from A2MC2-infected cells and IFN-α at 1000 U/ml were included as controls. (b) Activation of 539	
ISG15 expression in infected MARC-145 cells (24 hpi) detected by real-time PCR. “**” denotes 540	
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a significant difference compared to the mock-infected cells (P < 0.01). (c) The increase of 541	
STAT2 and RIG-I protein levels in rA2MC2-infected MARC-145 cells determined by Western 542	
blotting. Sample of cells infected with parental A2MC2 were included as a control.  543	
Fig. 4. Pig test of the rA2MC2 and its parent virus. Four pigs from each group were euthanized 544	
at 14 days post infection (DPI). Mock-infected pigs (PBS) were included as controls. (a). Gross 545	
lung lesion scores. Median values are shown. Error bars represent standard errors of the scores 546	
among the four pigs in each group. NS: no significant difference. (b). Viremia on DPI14 detected 547	
by RT-qPCR.  548	
Fig. 5. Chimeric cDNA infectious clones and growth property of the chimeric viruses. (a) 549	
Schematic illustration of the strategy for the construction of chimeric cDNA infectious clones via 550	
fragment swapping between PRRSV strains VR-2385 and A2MC2. The numbers above pIR-551	
VR2385 denote nucleotide positions in the VR-2385 genome. The restriction enzymes used for 552	
the fragment swapping are indicated below the pIR-VR2385 box. The shaded boxes indicate 553	
fragments from strain A2MC2. H-RZ: hammerhead ribozyme; F1 to F4: fragment 1 to 4; P(A): 554	
poly(A); D-RZ: hepatitis delta virus ribozyme; pIR-VR/A2F2: pIR-VR2385/A2F2. (b) Multi-555	
step growth curve in MARC-145 cells infected with the virus at an MOI of 0.01. The virus titers 556	
(log10 TCID50/ml) were determined in MARC-145 cells. rVR2385: recovered virus from the cells 557	
transfected with pIR-VR2385; rA2F2: recovered chimeric virus from pIR-VR/A2F2; rA2F3: 558	
recovered chimeric virus from pIR-VR/A2F3; rA2F123: recovered chimeric virus from pIR-559	
VR/A2F123; rA2MC2: recovered virus from pIR-A2MC2. (c) Plaque assay in MARC-145 cells. 560	
The bars in the images correspond to 10 mm.  561	
Fig. 6. The middle half of A2MC2 genome is essential for the interferon induction. (a) Interferon 562	
bioassay in Vero cells. Cell culture supernatants from MARC-145 cells infected with the 563	
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chimeric viruses were collected and used to treat Vero cells at indicated dilutions. rVR: 564	
rVR2385. (b) The increase of RIG-I protein level in MARC-145 cells infected with rA2F123 565	
chimeric virus determined by Western blotting. Samples of cells infected with rVR2385 and 566	
parental A2MC2 were included as controls. 567	
 568	
Fig.	1.	Construction	of	a	cDNA	infectious	clone	of	PRRSV	strain	A2MC2.	(a)	Schematic	
illustration	of	the	strategy	for	the	cloning	of	A2MC2	cDNA	into	pCAGEN vector.	F1,	F2,	F3,	and	
F4	denote	four	fragments	amplified	from	cDNA	of	A2MC2.	The	numbers	4545,	7692,	and	
12709	above	the	insert	indicate	nucleotide	positions	of	the	restriction	enzymes	FseI,	PmeI and	
BsrGI in	the	cDNA	of	A2MC2	(GenBank accession	number	JQ087873).	The	lower	four	lines	
indicate	PCR	amplified	fragments.	The	five	restriction	enzymes	used	to	assemble	the	full-
length	cDNA	are	indicated	above	each	fragment.	H-Rz:	hammerhead	ribozyme.	D-Rz:	hepatitis	
delta	virus	ribozyme.	(b)	Immunofluorescence	assay	(IFA)	of	MARC-145	cells	infected	with	
recovered	virus	from	the	cDNA	infectious	clone	of	A2MC2	(rA2MC2).	
Fig. 2. Growth property of the rA2MC2 virus. (a) Multi-step	growth	curve	of	the	rA2MC2	
virus.	MARC-145	cells	were	infected	with	rA2MC2	virus	at	an	MOI	of	1,		0.1,	and	0.01,	
respectively.	Culture	supernatants	were	collected	daily	for	virus	yield	titration.	The	virus	titers	
(log10 TCID50/ml)	were	determined	in	MARC-145	cells.	Error	bars	represent	standard	errors	of	
three	repeated	experiments.	Wild	type	parental	A2MC2	virus	was	included	as	a	control	(0.1	
MOI	WT).	(b)	Plaque	assay	of	rA2MC2	and	parental	A2MC2	virus	in	MARC-145	cells.	The	bars
in	the	images	correspond	to	10	mm.	
Fig. 3. The rA2MC2 virus induces type I interferons in MARC-145 cells. (a) Interferon 
bioassay in Vero cells. Cell culture supernatants from rA2MC2-infected MARC-145 cells 
collected at 24 hpi were diluted and added to Vero cells. 12 h later, the cells were infected with 
NDV-GFP. Fluorescence microscopy was conducted 24 h after NDV-GFP inoculation. Culture 
supernatant from A2MC2-infected cells and IFN-α at 1000 U/ml were included as controls. (b) 
Activation of ISG15 expression in infected MARC-145 cells (24 hpi) detected by real-time 
PCR. “**” denotes a significant difference compared to the mock-infected cells (P < 0.01). (c) 
Increase of STAT2 and RIG-I protein levels in rA2MC2-infected MARC-145 cells determined 
by Western blotting. 
Fig.	4.	Pig	test	of	the	rA2MC2	and	its	parent	virus.	Four	pigs	from	each	group	were	euthanized	
at	14	days	post	infection	(DPI). Mock-infected	pigs	(PBS)	were	included	as	controls.	(a) Gross
lung	lesion	scores.	Median	values	are	shown.	Error	bars	represent	standard	errors	of	the	
scores	among	the	four	pigs	in	each	group. NS:	no	significant	difference. (b).	Viremia	on	DPI14	
detected	by	RT-qPCR.	
Fig. 5. Chimeric cDNA infectious clones and growth property of the chimeric viruses. (a) Schematic 
illustration of the strategy for the construction of chimeric cDNA infectious clones via fragment swapping 
between PRRSV strains VR-2385 and A2MC2. The numbers above pIR-VR2385 denote nucleotide 
positions in the VR-2385 genome. The restriction enzymes used for the fragment swapping are indicated 
below the pIR-VR2385 box. The shaded boxes indicate fragments from strain A2MC2. H-RZ: hammerhead 
ribozyme; F1 to F4: fragment 1 to 4; P(A): poly(A); D-RZ: hepatitis delta virus ribozyme; pIR-VR/A2F2: 
pIR-VR2385/A2F2. (b) Multi-step growth curve in MARC-145 cells infected with the virus at an MOI of 
0.01. The virus titers (log10 TCID50/ml) were determined in MARC-145 cells. rVR2385: recovered virus 
from the cells transfected with pIR-VR2385; rA2F2: recovered chimeric virus from pIR-VR/A2F2; rA2F3: 
recovered chimeric virus from pIR-VR/A2F3; rA2F123: recovered chimeric virus from pIR-VR/A2F123; 
rA2MC2: recovered virus from pIR-A2MC2. (c) Plaque assay in MARC-145 cells. The bars in the images 
correspond to 10 mm. 
Fig. 6. The middle half of A2MC2 genome is essential for the interferon induction. (a)
Interferon bioassay in Vero cells. Cell culture supernatants from MARC-145 cells infected with 
the chimeric viruses were collected and used to treat Vero cells at indicated dilutions. rVR: 
rVR2385. (b) Increase of RIG-I protein level in MARC-145 cells infected with rA2F123 
chimeric virus determined by Western blotting. 
